NEW YORK, NY / ACCESSWIRE / June 27, 2017 / Shares of RAD were on fire in Monday trading as speculation heated up about Walgreens Boot Alliance gaining approval from the FTC to acquire the chain. Regulators have been reviewing the deal between the companies for months now and many on the Street have wondered if the deal would ever happen. Shares of RAD yesterday saw their largest increase since 2015. Shares of CVS also saw a modest gain in all of the excitement.

RDI Initiates Coverage on:

CVS Health Corporation
https://ub.rdinvesting.com/news/?ticker=CVS

Rite Aid Corporation
https://ub.rdinvesting.com/news/?ticker=RAD

CVS Health Corporation closed up 3.50% on Monday. The pharmacy drug store chain felt the excitement as traders became optimistic that the huge deal between Walgreens and Rite Aid may finally be approved this week by the FTC. It's been well over a year since Walgreens has started the takeover process for Rite Aid. There was no significant news from CVS itself yesterday but earlier in the year the company announced that stores would start looking different. The chain, which operates 8,000 drugstores, said that it plans to dramatically upgrade hundreds of its stores. There will be "trend wall" displays and trendy brands like Wunder2 and Tigi will be featured in these displays. Shares of CVS are up 1.5% year to date.

Access RDI's CVS Health Research Report at:
https://ub.rdinvesting.com/news/?ticker=CVS

Rite Aid Corporation's shares exploded in yesterday trading and closed up 30.23%. The stock saw an incredible 136 million shares traded roughly compared to an average of just 25 million usually. The news that traders have long been waiting for has finally arrived in regards to the company's ongoing acquisition deal with Walgreen Boots Alliance. According to news outlet CTFN, a vote from the FTC on the deal is likely to come this very week. The report cited both antitrust lawyers and DOJ officials who have said it's "more likely than not" that the merger will be approved. Current RAD prices are trading around 40% lower than what the two companies had agreed upon for an acquisition price. The initial price had been $9 then was lowered to $7 in January of this year when RAD shares started to drop. The deal has been under intense scrutiny from the FTC and traders had believed it would never even happen.

Access RDI's Rite Aid Research Report at:
https://ub.rdinvesting.com/news/?ticker=RAD

Our Actionable Research on CVS Health Corporation (NYSE: CVS) and Rite Aid Corporation (NYSE: RAD) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com